We are live on
!
Find out more
MC
Muhlenkamp & Co Portfolio holdings
AUM
$380M
1-Year Est. Return
43.74%
This Fund
S&P 500
This Quarter
Est. Return
+13.28%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$287M
AUM Growth
+$26.5M
(+10%)
Cap. Flow
-$4.21M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
49.28%
Holding
35
New
3
Increased
5
Reduced
23
Closed
–
Top Buys
| 1 |
EQT Corp
EQT
|
+$9.29M |
| 2 |
Franco-Nevada
FNV
|
+$1.93M |
| 3 |
Royal Gold
RGLD
|
+$1.71M |
| 4 |
LYLT
Loyalty Ventures Inc. Common Stock
LYLT
|
+$1.59M |
| 5 |
Invesco BuyBack Achievers ETF
PKW
|
+$541K |
Top Sells
| 1 |
Cameco
CCJ
|
+$5.2M |
| 2 |
SPDR Gold Trust
GLD
|
+$4.33M |
| 3 |
Rush Enterprises Class A
RUSHA
|
+$4.11M |
| 4 |
Bread Financial
BFH
|
+$2.35M |
| 5 |
Microchip Technology
MCHP
|
+$1.83M |
Sector Composition
| 1 | Technology | 20.3% |
| 2 | Industrials | 18.21% |
| 3 | Healthcare | 17.09% |
| 4 | Consumer Discretionary | 13.9% |
| 5 | Financials | 9.64% |
Similar funds
AC
MW
EAM
RWA
CSWG
BP
NICM
KFS
Muhlenkamp & Co's Q4 2021 Portfolio in Review
As of Q4 2021, Muhlenkamp & Co held 35 positions worth $287M, up 10% from $260M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Muhlenkamp & Co's Q4 2021 filing shows 3 new, 5 increased and 23 reduced positions. Its largest new stake was EQT Corp: 444,283 shares worth $9.69M. The largest sale was Cameco, an estimated $5.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
- Muhlenkamp & Co's largest Q4 2021 buy was EQT Corp: 444,283 shares worth $9.69M.
- Muhlenkamp & Co added most to Franco-Nevada in Q4 2021, an estimated $1.93M increase.
- Muhlenkamp & Co's biggest Q4 2021 reduction was Cameco, cutting an estimated $5.2M.
- Muhlenkamp & Co's ten largest holdings make up 49% of its $287M portfolio in Q4 2021.
- Muhlenkamp & Co opened 3 new positions and closed 0 in Q4 2021.
- Muhlenkamp & Co's portfolio value rose 10% quarter-over-quarter to $287M.
Based on Muhlenkamp & Co's 13F filing for Q4 2021, filed 29 Mar 2022.